$2.44 Billion is the total value of Redmile Group, LLC's 69 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 12.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FOLD | Sell | AMICUS THERAPEUTICS INC | $247,249,924 | +9.0% | 20,249,789 | -6.8% | 10.11% | +15.0% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $150,252,217 | +13.5% | 1,896,645 | -0.2% | 6.15% | +19.7% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $144,283,578 | +166.3% | 2,632,912 | +65.5% | 5.90% | +180.9% |
| REPL | Buy | REPLIMUNE GROUP INC | $131,422,485 | +108.8% | 4,831,709 | +32.5% | 5.38% | +120.1% |
| FATE | FATE THERAPEUTICS INC | $130,738,370 | -55.0% | 12,957,222 | 0.0% | 5.35% | -52.5% | |
| ISEE | Buy | IVERIC BIO INC | $96,390,197 | +58.0% | 4,502,111 | +32.4% | 3.94% | +66.7% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $93,071,124 | +8.8% | 2,360,414 | -0.4% | 3.81% | +14.7% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $88,134,991 | +57.9% | 1,977,451 | -0.4% | 3.60% | +66.5% |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $74,973,319 | -20.4% | 3,878,599 | -14.0% | 3.07% | -16.0% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $69,247,658 | -18.0% | 1,770,587 | -0.1% | 2.83% | -13.5% |
| KYMR | Sell | KYMERA THERAPEUTICS INC | $66,738,972 | +6.6% | 2,673,837 | -7.0% | 2.73% | +12.4% |
| LIVN | Sell | LIVANOVA PLC | $61,449,956 | -21.2% | 1,106,409 | -28.0% | 2.51% | -16.9% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $58,894,466 | +7.1% | 3,593,317 | +20.9% | 2.41% | +12.9% |
| IGMS | IGM BIOSCIENCES INC | $56,717,379 | -25.2% | 3,334,355 | 0.0% | 2.32% | -21.1% | |
| ARGX | Sell | ARGENX SEsponsored adr | $56,262,695 | -43.1% | 148,517 | -47.0% | 2.30% | -40.0% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $50,811,128 | +368.0% | 318,945 | +291.5% | 2.08% | +393.6% |
| PEN | Buy | PENUMBRA INC | $49,343,630 | +45.6% | 221,809 | +24.1% | 2.02% | +53.5% |
| New | ZYMEWORKS DEL INC | $48,542,715 | – | 6,175,918 | +100.0% | 1.99% | – | |
| RGNX | Sell | REGENXBIO INC | $43,398,452 | -14.4% | 1,913,512 | -0.2% | 1.78% | -9.7% |
| IMGN | Sell | IMMUNOGEN INC | $42,322,772 | +3.6% | 8,532,817 | -0.2% | 1.73% | +9.2% |
| New | PRIME MEDICINE INC | $41,049,723 | – | 2,209,350 | +100.0% | 1.68% | – | |
| RPTX | REPARE THERAPEUTICS INC | $39,487,465 | +21.3% | 2,684,396 | 0.0% | 1.62% | +27.9% | |
| ONEM | Sell | 1LIFE HEALTHCARE INC | $38,877,904 | -44.5% | 2,326,625 | -43.1% | 1.59% | -41.5% |
| NRIX | Sell | NURIX THERAPEUTICS INC | $32,948,608 | -15.9% | 3,000,784 | -0.2% | 1.35% | -11.3% |
| OSH | Buy | OAK STR HEALTH INC | $30,557,472 | +17.4% | 1,420,617 | +33.9% | 1.25% | +23.9% |
| Sell | VENTYX BIOSCIENCES INC | $29,346,197 | -38.4% | 894,974 | -34.4% | 1.20% | -35.1% | |
| ADCT | Buy | ADC THERAPEUTICS SA | $29,148,860 | -19.5% | 7,590,849 | +1.0% | 1.19% | -15.1% |
| SYK | Sell | STRYKER CORPORATION | $25,886,601 | -18.8% | 105,880 | -32.7% | 1.06% | -14.3% |
| Sell | ENTRADA THERAPEUTICS INC | $25,067,540 | -18.6% | 1,854,108 | -5.1% | 1.02% | -14.2% | |
| GRTS | Sell | GRITSTONE BIO INC | $23,913,537 | +33.8% | 6,931,460 | -0.3% | 0.98% | +41.1% |
| VERV | Sell | VERVE THERAPEUTICS INC | $23,643,823 | -54.3% | 1,221,903 | -18.8% | 0.97% | -51.8% |
| CNC | Sell | CENTENE CORP DEL | $23,066,133 | +5.0% | 281,260 | -0.4% | 0.94% | +10.8% |
| AUGX | AUGMEDIX INC | $22,433,310 | +7.6% | 14,380,327 | 0.0% | 0.92% | +13.5% | |
| ALLK | ALLAKOS INC | $21,431,216 | +37.6% | 2,545,275 | 0.0% | 0.88% | +45.2% | |
| ATRA | ATARA BIOTHERAPEUTICS INC | $20,476,240 | -13.2% | 6,242,756 | 0.0% | 0.84% | -8.4% | |
| ANTM | Sell | ELEVANCE HEALTH INC | $19,990,441 | -37.6% | 38,970 | -44.7% | 0.82% | -34.1% |
| IMVT | New | IMMUNOVANT INC | $19,314,325 | – | 1,088,131 | +100.0% | 0.79% | – |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $18,967,171 | -12.8% | 2,095,820 | -33.3% | 0.78% | -8.1% |
| ANNX | ANNEXON INC | $18,111,492 | -16.3% | 3,503,190 | 0.0% | 0.74% | -11.8% | |
| Sell | STEVANATO GROUP S P A | $16,937,174 | +5.6% | 942,525 | -0.5% | 0.69% | +11.4% | |
| ABSCI CORPORATION | $16,865,297 | -32.9% | 8,031,094 | 0.0% | 0.69% | -29.2% | ||
| RAPT | RAPT THERAPEUTICS INC | $15,539,674 | -17.7% | 784,832 | 0.0% | 0.64% | -13.1% | |
| RVMD | REVOLUTION MEDICINES INC | $14,887,500 | +20.8% | 625,000 | 0.0% | 0.61% | +27.4% | |
| STTK | SHATTUCK LABS INC | $12,925,802 | -14.8% | 5,619,914 | 0.0% | 0.53% | -10.2% | |
| MDVL | MEDAVAIL HOLDINGS INC | $10,374,434 | -61.4% | 34,604,516 | 0.0% | 0.42% | -59.3% | |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $10,053,883 | -44.2% | 266,187 | -34.7% | 0.41% | -41.2% |
| LVTX | LAVA THERAPEUTICS NV | $9,856,686 | -23.4% | 2,816,196 | 0.0% | 0.40% | -19.2% | |
| ALVR | ALLOVIR INC | $9,787,881 | -35.0% | 1,907,969 | 0.0% | 0.40% | -31.5% | |
| SCIENCE 37 HOLDINGS INC | $8,224,379 | -74.2% | 19,808,234 | 0.0% | 0.34% | -72.8% | ||
| ALXO | Sell | ALX ONCOLOGY HLDGS INC | $6,846,187 | -4.9% | 607,470 | -19.2% | 0.28% | +0.4% |
| STOK | Sell | STOKE THERAPEUTICS INC | $5,929,629 | -44.7% | 642,430 | -23.1% | 0.24% | -41.6% |
| NUVB | NUVATION BIO INC | $5,819,537 | -14.3% | 3,031,009 | 0.0% | 0.24% | -9.5% | |
| CABA | Sell | CABALETTA BIO INC | $4,294,331 | +848.0% | 464,252 | -33.3% | 0.18% | +877.8% |
| NVTA | INVITAE CORP | $4,241,550 | -24.4% | 2,280,403 | 0.0% | 0.17% | -20.2% | |
| Sell | SOMALOGIC INC | $3,765,000 | -30.6% | 1,500,000 | -19.8% | 0.15% | -26.7% | |
| TKNO | ALPHA TEKNOVA INC | $3,147,678 | +68.9% | 558,099 | 0.0% | 0.13% | +79.2% | |
| STXS | STEREOTAXIS INC | $3,079,115 | +15.0% | 1,487,495 | 0.0% | 0.13% | +21.2% | |
| GRFS | New | GRIFOLS S Asp adr rep b nvt | $2,767,600 | – | 325,600 | +100.0% | 0.11% | – |
| THE ONCOLOGY INSTITUTE INC | $2,612,211 | -64.4% | 1,583,158 | 0.0% | 0.11% | -62.3% | ||
| HOOK | Sell | HOOKIPA PHARMA INC | $2,522,962 | -58.7% | 3,114,768 | -31.7% | 0.10% | -56.5% |
| Sell | INVIVYD INC | $2,161,088 | -64.1% | 1,440,725 | -25.0% | 0.09% | -62.2% | |
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $1,447,280 | -60.2% | 1,608,089 | 0.0% | 0.06% | -58.2% | |
| SONENDO INC | $1,409,711 | +164.5% | 498,131 | 0.0% | 0.06% | +176.2% | ||
| BVS | Sell | BIOVENTUS INC | $1,398,830 | -84.6% | 535,950 | -58.7% | 0.06% | -83.9% |
| XERIS BIOPHARMA HOLDINGS INC | $1,391,961 | -14.8% | 1,046,587 | 0.0% | 0.06% | -9.5% | ||
| NLTX | Sell | NEOLEUKIN THERAPEUTICS INC | $941,938 | -57.2% | 1,850,566 | -46.2% | 0.04% | -54.1% |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $730,501 | -62.9% | 731,379 | -33.2% | 0.03% | -60.5% |
| CTSO | CYTOSORBENTS CORP | $412,866 | +14.1% | 266,365 | 0.0% | 0.02% | +21.4% | |
| BCEL | Sell | ATRECA INC | $354,388 | -71.8% | 442,653 | -44.7% | 0.01% | -71.4% |
| HUM | Exit | HUMANA INC | $0 | – | -16,961 | -100.0% | -0.32% | – |
| CUTR | Exit | CUTERA INC | $0 | – | -194,573 | -100.0% | -0.34% | – |
| SKIN | Exit | THE BEAUTY HEALTH COMPANY | $0 | – | -2,109,564 | -100.0% | -0.96% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -525,575 | -100.0% | -1.24% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -5,765,818 | -100.0% | -1.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.